由大鼠体内分布估算6-~(18)F-L-多巴在人体内的吸收剂量
Estimation of Radiation Absorbed Doses for 6-~(18)F-L-DOPA in Human Based on Rats Biodistribution
-
摘要: 在大鼠尾静脉注射6-18F-L-多巴(18F-DOPA)后5、30、60、90、120和150min时处死动物,测定大鼠体内各脏器中18F活度分布,换算至标准人体内分布,按MIRD法估算人体18F-DOPA内照射吸收剂量。估算结果表明,肾脏的内照射吸收剂量最高,为22.9pGy/Bq,脑的内照射吸收剂量为11.8pGy/Bq,其它脏器的内照射吸收剂量为(9~18)pGy/Bq,有效剂量当量为20.5pSv/Bq。这表明,由大鼠体内分布资料可估算18F-DOPA在人体内的吸收剂量,为临床安全应用18F-DOPA提供了参考资料。Abstract: To estimate the radiation absorbed doses in humans due to intravenous administration of 618FLDOPA(18FDOPA) based on rats biodistribution data and appraise the security of 18FDOPA in humans. At 5, 30, 60, 90, 120 and 150 min after 18FDOPA is injected into rats through a tail vein, the rats are killed by cervical fracture and biodistributions in rats are determined. Radiation dosimetry in humans are calculated on the base of activity distribution in rats and the standard MIRD method using radioactivitytime curves for humans. The kidney is the organ receiving highest dose of 22.9 pGy/Bq, the brain receives a dose of 11.8 pGy/Bq, and other organs receive doses between 9 and 18 pGy/Bq. The effective dose is estimated to be 20.5 pSv/Bq. The results demonstrate that human radiation dosimetry can be estimated by the rats biodistribution data and provide an important data for clinical safe trial of 18FDOPA.